Iterum Therapeutics (ITRM) Institutional Ownership $1.50 +0.01 (+0.34%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$1.52 +0.02 (+1.34%) As of 02/21/2025 06:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Iterum Therapeutics (NASDAQ:ITRM)CurrentInstitutional OwnershipPercentage9.21%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$1.00MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$229.43K Get ITRM Insider Trade Alerts Want to know when executives and insiders are buying or selling Iterum Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ITRM Institutional Buying and Selling by Quarter Iterum Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/18/2025 Alpine Global Management LLC15,000$27K0.0%-76.9%0.055% 2/17/2025 Two Sigma Investments LP25,245$45K0.0%N/A0.092% 2/17/2025 Citadel Advisors LLC21,207$38K0.0%N/A0.077% 2/14/2025 Alpine Global Management LLC15,000$27K0.0%-76.9%0.055% 2/13/2025 Renaissance Technologies LLC438,816$777K0.0%N/A1.595% 1/31/2025 Sanctuary Advisors LLC20,000$35K0.0%N/A0.073% 1/30/2025 Lee Financial Co16,000$28K0.0%N/A0.058% 1/28/2025 Apollon Financial LLC250,250$443K0.1%+11.3%0.909% 11/15/2024 XTX Topco Ltd33,040$36K0.0%N/A0.146% 8/9/2024 Renaissance Technologies LLC64,022$73K0.0%-42.0%0.387% Get the Latest News and Ratings for ITRM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/4/2023 Apollon Wealth Management LLC200,000$214K0.0%N/A1.542% 11/10/2022 New Leaf Venture Partners L.L.C.97,084$157K0.1%-93.3%0.794% 10/6/2022 Krilogy Financial LLC20,000$32K0.0%-90.0%0.163% 7/14/2022 Krilogy Financial LLC200,000$40K0.0%N/A0.109% 11/16/2021 Squarepoint Ops LLC52,503$29K0.0%+106.9%0.029% 11/15/2021 Franklin Resources Inc.384,200$215K0.0%N/A0.210% 11/12/2021 Renaissance Technologies LLC644,567$360K0.0%-80.4%0.353% 10/25/2021 Krilogy Financial LLC81,000$45K0.0%+161.3%0.044% 9/17/2021 Virtu Financial LLC83,658$193K0.0%-37.2%0.046% 8/17/2021 Millennium Management LLC2,560,381$5.91M0.0%+3,304.5%1.429% 8/16/2021 Squarepoint Ops LLC25,382$59K0.0%-49.4%0.014% 8/16/2021 Cubist Systematic Strategies LLC89,431$207K0.0%N/A0.050% 8/13/2021 Renaissance Technologies LLC3,289,300$7.60M0.0%N/A1.836% 8/13/2021 Sigma Planning Corp17,153$40K0.0%N/A0.010% 8/13/2021QS Investors LLC384,200$888K0.0%N/A0.214% 8/12/2021 Insight Advisors LLC PA35,000$28K0.0%-88.5%0.020% 8/11/2021 Susquehanna Fundamental Investments LLC66,230$153K0.0%N/A0.037% 8/10/2021National Asset Management Inc.32,100$75K0.0%-61.0%0.018% 8/4/2021 Grimes & Company Inc.146,278$338K0.0%+17.4%0.082% 7/15/2021 Focused Wealth Management Inc100,000$231K0.0%+33.3%0.056% 5/21/2021 Citadel Advisors LLC137,026$193K0.0%-14.5%0.076% 5/19/2021 Virtu Financial LLC133,197$188K0.0%+209.0%0.074% 5/19/2021 Squarepoint Ops LLC50,196$71K0.0%N/A0.028% 5/18/2021 Millennium Management LLC75,206$106K0.0%N/A0.042% 5/18/2021 Verition Fund Management LLC112,500$159K0.0%N/A0.063% 5/18/2021 Citadel Advisors LLC137,026$193K0.0%-14.5%0.076% 5/18/2021 Jane Street Group LLC18,041$25K0.0%N/A0.010% 5/17/2021 Royal Bank of Canada19,000$27K0.0%N/A0.011% 5/17/2021 Edmond DE Rothschild Holding S.A.100,000$141K0.0%N/A0.056% 5/17/2021 HRT Financial LP399,479$563K0.0%+3,875.3%0.223% Why Buffett and 100 members of Congress are Piling into this One Investment (Ad)This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>>5/13/2021 Barclays PLC50,000$71K0.0%N/A0.028% 5/12/2021 Geode Capital Management LLC96,173$135K0.0%+190.4%0.054% 5/12/2021 Grimes & Company Inc.124,637$176K0.0%+73.1%0.070% 5/12/2021 FineMark National Bank & Trust300,000$423K0.0%N/A0.167% 5/12/2021 UBS Group AG52,961$75K0.0%N/A0.030% 5/4/2021 Commonwealth Equity Services LLC18,500$26K0.0%N/A0.010% 2/25/2021 Clear Street Markets LLC55,000$54K0.0%N/A0.045% 2/24/2021 Virtu Financial LLC43,111$43K0.0%N/A0.036% 2/10/2021 Renaissance Technologies LLC732,900$725K0.0%N/A1.493% 2/9/2021 Pivotal bioVenture Partners Investment Advisor LLC945,085$935K0.3%N/A1.926% (Data available from 1/1/2016 forward) ITRM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ITRM shares? During the previous two years, 9 institutional investors and hedge funds held shares of Iterum Therapeutics. The most heavily invested institutionals were Renaissance Technologies LLC ($777K), Apollon Financial LLC ($443K), Apollon Wealth Management LLC ($214K), Two Sigma Investments LP ($45K), Citadel Advisors LLC ($38K), XTX Topco Ltd ($36K), and Sanctuary Advisors LLC ($35K).Learn more on ITRM's institutional investors. What percentage of Iterum Therapeutics stock is owned by institutional investors? 9.21% of Iterum Therapeutics stock is owned by institutional investors. Learn more on ITRM's institutional investor holdings. Which institutional investors have been buying Iterum Therapeutics stock? The following institutional investors have purchased Iterum Therapeutics stock in the last 24 months: Renaissance Technologies LLC ($438.82K), Apollon Wealth Management LLC ($200K), XTX Topco Ltd ($33.04K), Apollon Financial LLC ($25.50K), Two Sigma Investments LP ($25.25K), Citadel Advisors LLC ($21.21K), and Sanctuary Advisors LLC ($20K). How much institutional buying is happening at Iterum Therapeutics? Institutional investors have bought a total of 779,808 shares in the last 24 months. This purchase volume represents approximately $1.22M in transactions. Which Iterum Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Iterum Therapeutics stock in the last 24 months: Alpine Global Management LLC ($99.67K), and Renaissance Technologies LLC ($46.30K). How much institutional selling is happening at Iterum Therapeutics? Institutional investors have sold a total of 145,970 shares in the last 24 months. This volume of shares sold represents approximately $229.43K in transactions. Related Companies Acrivon Therapeutics Major Shareholders Cidara Therapeutics Major Shareholders Alector Major Shareholders Aclaris Therapeutics Major Shareholders Inhibikase Therapeutics Major Shareholders Greenwich LifeSciences Major Shareholders Innate Pharma Major Shareholders Fate Therapeutics Major Shareholders Checkpoint Therapeutics Major Shareholders Solid Biosciences Major Shareholders This page (NASDAQ:ITRM) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iterum Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Iterum Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ITRM Stock Alerts